Share Name Share Symbol Market Type Share ISIN Share Description
Fevertree Drinks LSE:FEVR London Ordinary Share GB00BRJ9BJ26 ORD 0.25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +11.00p +0.46% 2,386.00p 2,389.00p 2,393.00p 2,403.00p 2,358.00p 2,365.00p 361,438 16:35:17
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Beverages 102.2 34.3 23.9 100.0 2,749.65

Fevertree (FEVR) Latest News

More Fevertree News
Fevertree Takeover Rumours

Fevertree (FEVR) Share Charts

1 Year Fevertree Chart

1 Year Fevertree Chart

1 Month Fevertree Chart

1 Month Fevertree Chart

Intraday Fevertree Chart

Intraday Fevertree Chart

Fevertree (FEVR) Discussions and Chat

Fevertree Forums and Chat

Date Time Title Posts
19/8/201720:30FEVER TREE with chart899
19/8/201708:44Fevertree Drinks PLC (Fever-Tree)1,135
07/11/201423:50Is Fever Tree fairly Valued?-

Add a New Thread

Fevertree (FEVR) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Fevertree trades in real-time

Fevertree (FEVR) Top Chat Posts

DateSubject
19/8/2017
09:20
Fevertree Daily Update: Fevertree Drinks is listed in the Beverages sector of the London Stock Exchange with ticker FEVR. The last closing price for Fevertree was 2,375p.
Fevertree Drinks has a 4 week average price of 1,737p and a 12 week average price of 1,592p.
The 1 year high share price is 2,449p while the 1 year low share price is currently 918p.
There are currently 115,240,896 shares in issue and the average daily traded volume is 836,685 shares. The market capitalisation of Fevertree Drinks is £2,749,647,778.56.
04/8/2017
10:59
finbarot: this feels like another big move up but I suppose with the share price where it is, its not a big move at all?
18/7/2017
07:41
sogoesit: From the Independent Investment Trust's (IIT) Chairman's statement today: "Once again, Fever-Tree's performance, both operationally and in share price terms, has been such as to justify a paragraph to itself. Sales growth in all markets, but most particularly in the UK (arguably its most mature market), has been quite extraordinary. The stockmarket was unusually slow to recognize the implications of this at the time of the annual sales announcement, offering us a chance to add to our already large holding on advantageous terms. It can be argued that the shares are now generously valued in relation to market expectations, but such expectations have been hopelessly low in the past. Moreover, we place considerable value on the company's dominant position in the global market for premium soft drink mixers. At the moment, the risk of selling too early, a sin we have already committed on more than one occasion, looks at least as big as the risk of selling too late."
13/7/2017
10:07
christh: Consensus recommendation As of Jul 07, 2017, the consensus forecast amongst 4 polled investment analysts covering Fevertree Drinks PLC advises that the company will outperform the market. This has been the consensus forecast since the sentiment of investment analysts deteriorated on May 05, 2017. The previous consensus forecast advised investors to purchase equity in Fevertree Drinks PLC. Share price forecast The 3 analysts offering 12 month price targets for Fevertree Drinks PLC have a median target of 1,865.00, with a high estimate of 1,950.00 and a low estimate of 1,850.00. The median estimate represents a 8.75% increase from the last price of 1,715.00. Dividends In 2016, Fevertree Drinks PLC reported a dividend of 0.06 GBP, which represents a 102.92% increase over last year. The 4 analysts covering the company expect dividends of 0.07 GBP for the upcoming fiscal year, an increase of 13.60%. Fevertree Drinks Plc had revenues for the full year 2016 of 102.24m. This was 72.54% above the prior year's results. My comments The 2017 results are comfortably ahead of expectations (CEO comments)so there may be a significant growth above that. So well justified price target by the analysts. Read all in here in the Financial Times hTtps://markets.ft.com/data/equities/tearsheet/forecasts?s=FEVR:LSE&mhq5j=e2
22/6/2017
17:07
sogoesit: The article excerpt referred to in post 1013: "Fevertree (FEVR:AIM) £16.05 Current market status: LOVED Fevertree’s tonic water is increasingly the gin lover’s mixer of choice as it is considered a high quality product. The company has succeeded in getting its products stocked in a wide range of places, from supermarkets and restaurants to airlines and pubs. Fevertree has an asset-light, outsourced production model that means it is very cash generative and able to pay a progressive dividend. Its share price has risen 12-fold in value since joining the stock market in 2014. It has developed a reputation for providing conservative earnings guidance to analysts and subsequently over-delivering when financial numbers are reported. That has led to a continuous stream of earnings upgrades which have fuelled significant share price gains. FEVR - Comparison Line Chart (Rebased to first) WHAT ARE THE NEGATIVE POINTS FOR THE INVESTMENT CASE? 1. Could struggle to crack dark spirit market It is betting on a repeat of its tonic water success in the dark spirit mixers category. We think that’s a tall order. The market could punish the share price if the company cannot crack this market to same degree as it has done with light spirit mixers. Gin (a light spirit) and tonic is a refreshing drink where consumers clearly want high quality from both the spirit and the mixer, hence why Fevertree has done so well. However, dark spirits tend to be drunk neat, such as brandy, bourbon and whisky, so no need for fancy mixers. A mixer could cover up the true taste of whisky, for example, which defeats the object of enjoying that type of spirit. Water or ice would be acceptable mixers for whisky, but you don’t need a Fevertree-branded product. As for something like whisky and cola, surely that is the preferred drink of someone who is going after quantity over quality? Fevertree is now selling Madagascan Cola, which it claims to enhance ‘the complex flavours’ of the finest rums, whiskies and bourbons. Convincing shophisticated whisky drinkers to start adding cola to their favourite tipple will be a hard sell, in our opinion. 2. Is the business really worth £1.8bn? We note that Charles Rolls, one of the company’s founders and deputy chairman, last month sold £73.1m worth of shares. He cashed in £17.3m worth of shares when the company floated three years ago, plus earned £648,000 from Fevertree in pay and bonuses in 2016 alone – so hardly short of cash. Selling a large chunk now sends a negative signal to the market about the company’s future prospects. 3. Main Market plans We’ve heard talk that Fevertree is going to move to London’s Main Market. The company’s advisers say there are no plans at present, but we see this as a short-term risk to the share price if it does happen. The stock is a popular choice for investors wanting AIM shares that qualify for inheritance tax benefits. IHT portfolio managers would be forced to sell if Fevertree went to the Main Market as the shares would no longer qualify for the tax benefits."
10/6/2017
12:13
henchard: Here are some actual numbers for 2016 and forecast numbers for 2017 and 2018 (based on the current share price of 1,714p): ..........2016.....2017.....2018 EPS.......23.86p...27.68p...31.06p Growth....106.2%...16.0%....12.2% P/E.......71.8x....61.9x....55.2x Surely the shares are way too high at these P/Es for the forecast growth. The PEG ratio for 2017 is 3.9. For the PEG to get to the "fair value" benchmark of 1 (let alone a "growth-at-a-reasonable-price" level of below 1) FEVR would have to do EPS of 35.4p in 2017, which is 28% higher than the current consensus and 22% higher than the most bullish analyst, who's forecasting 29p EPS according to the FT. I could see FEVR beating EPS forecasts but not to the extent of 35.4p or higher. The alternative, of course, is that the share price would have to fall significantly for the valuation to become attractive.
27/5/2017
19:53
christh: Fever-Tree founder sells £73m worth of shares The next round is on Charles. Fever-Tree founder Charles Rolls has cashed in on the company’s recent success, taking advantage of its 900% share price increase to sell £73m worth of stock in the group. The mixer maker reported today that Mr Rolls had sold around 3.9% of the company’s shares to institutional investors at a price of £16.25 per share – a 6% discount on yesterday’s closing price. The total was 80% more than Mr Rolls had originally intended to sell, due to “significant institutional demand”. It’s not hard to see why people might be interested: shares in Fever-Tree have risen more than 50% this year alone and are currently up 924% since its IPO in late 2014. After the sale, Mr Rolls still owns around 11.2% of the company, and he has agreed not to dispose of any more shares in the next 6 months. https://www.ft.com/content/17771fdb-af77-3cd3-849d-78c417348081
24/5/2017
17:39
terry topper: In this instance I am inclined to believe that there is genuine institutional demand and Rolls is helping to meet this (while at the same time trousering a very large wedge!). In addition he is now non-exec and is a good bit older than Tim Warrillow. Warrillow must also have been asked if he wanted to participate, and declined which is a huge positive. It suggests that trading continues to be very strong in my view. I am also in no doubt that enquiries will have been made by the large multinational consumer groups so he will know that he has a straightforward exit at some point. Hopefully there will be significant demand that will leave new institutions looking to pick up additional shares after the placing to meet their 'unit' sizes. In that case I suspect the scenario that Villarich mentions above re G4M is highly likely and we could see the FEVR price heading towards £19-20.
16/5/2017
08:39
martywidget: May 16, 2017 at 05:00 AIM-listed premium soft drinks company Fevertree Drinks (FEVR) is on course to beat expectations this year but Shore Capital says there need to be significant upgrades to justify the current price. Analyst Phil Carroll retained his ‘hold’ recommendation on the stock, which was trading down 1%, or 18p, at £16.86 at the time of writing. Fevertree issued a trading update which shows it is maintaining momentum. ‘Despite an exceptional 2016, momentum in the first four months of 2017 is strong enough to justify management guiding to an expectation that results for the current year will be comfortably ahead of market expectations,’ said Carroll. ‘Following discussions with the company we expect to increase our revenue and profit before tax expectations by c.5%, noting our forecasts are starting ahead of consensus.’ An increase in forecasts would equate to profit before tax rising from £38.7 million to £40.6 million this year, which Carroll said would ‘imply the shares are trading on a full year 2017 price/earnings ratio of 59.6 times’. ‘Our analysis shows that the valuation requires significant upgrades to justify the current share price. Therefore, we retain our “hold” recommendation,’ he said. Http://citywire.co.uk/money/the-expert-view-888-fevertree-and-astrazeneca/a1016633?ref=citywire-money-latest-news-list#i=6
15/5/2017
08:33
topvest: What a great company this is. Trouble is that the share price is now so high that an AHEAD profit update is already priced in. More downside than upside in the share price if you ask me. If you logically put a cap on how much this brand could ultimately be worth (top-end) it can't be much more than £3-5bn and its already valued at £2bn. Just my view. Obviously I wasn't smart enough to spot this great company 2/3 years ago so well done to those that spotted this early.
06/4/2017
15:29
greek islander: New high of 1553 reached before a pull back. Share price looking stronger than ever. More news inside the next 2-3 months about current trading should further inflate the share price The market needs reassurance that revenue continues to rise and then we shall be looking at £20. wetdream, the Asos pe may look ridiculous but it has been double that and more in the past. It is the clear market leader with a huge loyal following and though I no longer hold it after cashing in at just under £40 more than a couple of years back. It has nearly always had the potential to be a £100 stock. Be interesting to see if FEVR which has more international revenue and therefore potential gets there before it.
Fevertree share price data is direct from the London Stock Exchange
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:42 V: D:20170820 01:59:13